Study immune-web changes in ER+ breast cancer on tamoxifen
Part of Cancer, Skin clinical trials.
This trial studies how the immune system forms “neutrophil extracellular traps” (immune web material) in people with ER-positive breast cancer who take tamoxifen. It aims to understand whether tamoxifen changes this immune activity over time, which may help explain how it works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and between 18 and 45, or between 46 and 50 if you have not had a period for 12 months
- Or you are 51 or older (menopause is defined as no periods for 12 months)
- You have ER-positive breast cancer (ER+ means the tumor grows using estrogen signals)
- You are taking tamoxifen for at least 6 months (or 0–6 months if you are in the control group)
- You are not pregnant
- You do not have certain immune/inflammation conditions or ongoing infections that affect immune function
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether low-dose tamoxifen (a breast cancer prevention drug) or omega-3 supplements can lower breast cancer risk in postmenopausal women who are overweight and have a higher chance of getting the disease. The study lasts about 6 months and involves blood draws and a breast fluid test to see how the treatment affects breast cells.
This study looks at how your immune system changes while you receive standard breast cancer treatments. The researchers measure immune-related signals during your treatment to better understand what may be happening in triple-negative or certain hormone-receptor breast cancers.
This study looks at how your immune system reacts to anti-HER2 treatments in people with HER2-positive breast cancer. It may help doctors understand who responds best by studying immune signals in blood (and sometimes tissue) during or after treatment.
This study looks at how your immune system changes while you receive standard breast cancer treatment around the time of surgery. The goal is to learn why some people respond better than others, which could help future treatment choices.
This study follows women with breast cancer and certain lymphomas to understand long-term sexual and reproductive health. It may help researchers better support patients’ body changes and wellness over time during and after treatment.
This study looks at how certain immune cells behave in people with breast cancer. It may help researchers understand the disease and how the immune system affects it.
Hear when a new Breast Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.